LYPLAL1 and breast carcinoma: Furthermore, LYPLAL1-DT expression was considerably diminished in 120 breast cancer samples compared to the paired nontumoral samples in the TCGA-BRCA cohort (Fig. 1G), which was verified in 24 pairs of para-cancerous breast and TNBC tissues by real-time quantitative polymerase chain reaction (RT-qPCR) in the Sun Yat-sen University Cancer Center (SYSUCC) cohort (Fig. 1H).